Philomena Kamya

Philomena Kamya is a healthcare, pharma/biotechnology specialist and finance professional with a strong background in Immunology.

She holds a Doctor of Philosophy (Ph.D.) in Immunology from McGill University with a remarkable Grade Point Average of 3.98/4.0.

Additionally, she studied as a Fellow in Immunology at Harvard Medical School, further solidifying her expertise in the field.

Philomena Kamya has held key positions in renowned organizations, including Director at Johnson & Johnson, with a focus on healthcare investments.

Previously, she contributed to the Dartmouth External Advisory Panel at Geisel School of Medicine at Dartmouth, showcasing her dedication to the medical field.

Her experience also includes roles such as Venture Partner at Elm Street Ventures, Portfolio Management at BridgeBio, and Biotechnology Equity Research at Stifel Financial Corp.

With a unique blend of skills in healthcare, biotechnology, and finance, Philomena Kamya offers valuable insights for biotech and healthcare investments.